Media Contact
-
Boehringer Ingelheim GmbH
Julia Meyer-Kleinmann
Science & Technology Communications
55216 Ingelheim am Rhein
Germany
Press Conferences
2nd International Boehringer Ingelheim Research & Development Press Conference
-
Research and Development 17 October 2008
2nd International Boehringer Ingelheim Research & Development Press Conference
Media event: The latest on new generation compounds and new therapeutic approaches - an exclusive update on progress in the Boehringer Ingelheim pipeline.
Venue:
Biberach, Germany, 17 Oct. 2008, 10:30 hrs (CEST)
Congress Overview
News & Information
-
News Releases
Disease
- Diabetes Facts & Figures - PDF (136 KB)
- Type 2 Diabetes - PDF (206 KB)
- Global Prevalence Type 2 Diabetes - PDF (273 KB)
- Treatments Type 2 Diabetes - PDF (233 KB)
- Discovery and treatment history Type 2 Diabetes - PDF (105 KB)
Speakers
Speakers
From Curiosity to Discovery:
Boehringer Ingelheim Research & Development
The Power of Curiosity
How creativity can fill the pipeline
Type 2 Diabetes
A new perspective on a growing epidemic and the need for continued development
Discovery in Diabetes: Boehringer Ingelheim enters Diabetes
The latest on new generation compounds and new therapeutic approaches
Joined presentation with Dr Michael Mark
Discovery in Diabetes: Boehringer Ingelheim enters Diabetes
The latest on new generation compounds and new therapeutic approaches
Joined presentation with Prof. Klaus Dugi
Discovery in Action
Landmark Trials & Pipeline Update
Images
Images & Videos
More images in the Boehringer Ingelheim media pool
-
Entry into Type 2 Diabetes
Dr Andreas Barner talks about progress in research, the Boehringer Ingelheim pipeline and potential future medications in diabetes
(Vice-Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine, Boehringer Ingelheim).
-
International R&D Press Conference
Highlights from Boehringer Ingelheim´s 2nd International Research & Development Press Conference in Biberach (Germany).
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
R&D Press Conference 2008
Boehringer Ingelheim´s 2nd International Research & Development Press Conference in Biberach (Germany) on 17 Oct. 2008
-
Dr Barner: Entry into Diabetes Field
Dr Andreas Barner announces entry into new therapeutic area Diabetes
(Vice-Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine, Boehringer Ingelheim)
-
Boehringer Ingelheim's 2nd International R&D Press Conference.
The power of curiosity leads to new discoveries at Boehringer Ingelheim.
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
R&D facility at the Biberach site (Germany)
Boehringer Ingelheim´s largest R&D centre in Biberach (Germany)
-
Albert Einstein quotation: Curiosity
"The important thing is not to stop questioning, curiosity has its own reason for existing." Albert Einstein